🇺🇸 Celecoxib capsule in United States

29 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Headache — 4 reports (13.79%)
  2. Nausea — 4 reports (13.79%)
  3. Vomiting — 4 reports (13.79%)
  4. Dizziness — 3 reports (10.34%)
  5. Haemorrhage — 3 reports (10.34%)
  6. Melaena — 3 reports (10.34%)
  7. Anaemia — 2 reports (6.9%)
  8. Condition Aggravated — 2 reports (6.9%)
  9. Drug Use Disorder — 2 reports (6.9%)
  10. Gastric Ulcer — 2 reports (6.9%)

Source database →

Celecoxib capsule in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Celecoxib capsule approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Celecoxib capsule in United States?

Xuhui Central Hospital, Shanghai is the originator. The local marketing authorisation holder may differ — check the official source linked above.